Skip to main content
. 2023 Jun 27;6(6):e2320400. doi: 10.1001/jamanetworkopen.2023.20400

Table 1. Baseline Characteristics of Study Participants.

Characteristic Participants, No. (%)
All (n = 294) Usual care group (n = 97)a App group (n = 99)b e-Help group (n = 98)c
Sociodemographic characteristics
Age, mean (SD) [range], y 50.6 (14.9) [18-86] 51.0 (15.2) [18-84] 50.3 (14.3) [18-80] 50.4 (15.1) [20-86]
BMI, mean (SD) [range] 26.8 (4.2) [17-41] 26.7 (4.2) [19-40] 26.9 (4.0) [19-39] 26.8 (4.4) [17-40]
Sex
Female 173 (58.8) 58 (59.8) 60 (60.6) 55 (56.1)
Male 121 (41.2) 39 (40.2) 39 (39.4) 43 (43.9)
Educational level, y
<10 26 (8.8) 7 (7.2) 10 (10.1) 9 (9.2)
10-12 88 (29.9) 31 (32.0) 28 (28.3) 29 (29.6)
>12 180 (61.2) 59 (60.8) 61 (61.6) 60 (61.2)
Full-time employment 158 (53.7) 47 (48.5) 57 (57.6) 54 (55.1)
Married or living with partner 221 (75.2) 72 (74.2) 72 (72.7) 77 (78.6)
Neck and low back pain history
Pain localization
Low back 166 (56.5) 53 (54.6) 52 (52.5) 61 (62.2)
Neck 46 (15.6) 13 (13.4) 18 (18.2) 22 (22.4)
Neck and low back 82 (27.9) 31 (32.0) 29 (29.3) 15 (15.3)
Days with pain in past year
0 2 (0.7) 1 (1.0) 1 (1.0) 0
1-7 5 (1.7) 1 (1.0) 1 (1.0) 3 (3.1)
8-30 16 (5.4) 7 (7.2) 5 (5.1) 4 (4.1)
>30 but not every day 89 (30.3) 24 (24.7) 38 (38.4) 27 (27.6)
Every day 182 (61.9) 64 (66.0) 54 (54.5) 64 (65.3)
Use of pain medication, d/wk
0 93 (31.6) 36 (37.1) 28 (28.3) 29 (29.6)
1-2 69 (23.5) 17 (17.5) 20 (20.2) 32 (32.7)
3-5 61 (20.7) 21 (21.6) 22 (22.2) 18 (18.4)
Every day 71 (24.1) 23 (23.7) 29 (29.3) 19 (19.4)
Baseline measure of primary outcome
Musculoskeletal Health Questionnaire, mean (SD)d 29.2 (8.5) 29.0 (9.0) 30.0 (9.1) 28.5 (7.1)
Baseline measures of secondary outcomes
Roland-Morris Disability Questionnaire, mean (SD)e,f 10.9 (5.1) 11.1 (5.0) 10.1 (5.3) 11.5 (4.9)
Neck Disability Index, mean (SD)g,h 18.3 (7.0) 17.8 (6.7) 18.1 (7.8) 19.1 (6.0)
Mean pain intensity in past wk (NRS), mean (SD)i 5.4 (1.8) 5.4 (1.8) 5.3 (2.0) 5.6 (1.6)
Worst pain intensity in past wk (NRS), mean (SD)i 7.0 (1.8) 6.9 (1.9) 6.8 (2.0) 7.2 (1.5)
EQ-VAS, mean (SD)j 53.0 (18.6) 50.7 (19.3) 55.7 (18.0) 52.5 (18.2)
EQ-5D (weighted), mean (SD)k 0.64 (0.15) 0.63 (0.14) 0.65 (0.17) 0.63 (0.14)
Pain Self-Efficacy Questionnaire, mean (SD)l 36.8 (13.3) 36.9 (13.1) 38.0 (13.1) 35.5 (13.6)
Brief Illness Perception Questionnaire, mean (SD)m 51.2 (9.2) 52.2 (8.4) 51.3 (9.4) 50.2 (9.7)

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); EQ-5D, EuroQoL 5-dimension questionnaire; EQ-VAS, EuroQol visual analog scale; NRS, numerical rating scale.

a

The usual care group received usual care only. Usual care comprised a clinical examination and an offer of suitable treatment in accordance with current evidence-based guidelines.

b

The app group received individually tailored app-delivered self-management support in addition to usual care.

c

The e-Help group received nontailored web-based self-management support in addition to usual care.

d

Score range, 0 to 56, with higher scores indicating better musculoskeletal health.

e

Score range, 0 to 24, with higher scores indicating more pain-related disability.

f

Includes 248 participants with low back pain or neck and low back pain (84 in the usual care group, 81 in the app group, and 83 in the e-Help group).

g

Score range, 0 to 50, with higher scores indicating more pain-related disability.

h

Includes 128 participants with neck pain or neck and low back pain (44 in the usual care group, 47 in the app group, and 37 in the e-Help group).

i

Scale range, 0 to 10, with higher scores indicating higher intensity level of pain.

j

Scale range, 0 to 100, with higher scores indicating better health status.

k

Score range, 0 to 1, with higher scores indicating better health status.

l

Score range, 0 to 60, with higher scores indicating greater confidence.

m

Score range, 0 to 80, with higher scores indicating greater illness perception.